deferoxamine has been researched along with B16 Melanoma in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, SA | 1 |
Son, YO | 1 |
Kook, SH | 1 |
Choi, KC | 1 |
Lee, JC | 1 |
Henderson, BR | 2 |
Kühn, LC | 2 |
Menotti, E | 1 |
Gabizon, A | 1 |
Price, DC | 1 |
Huberty, J | 1 |
Bresalier, RS | 1 |
Papahadjopoulos, D | 1 |
4 other studies available for deferoxamine and B16 Melanoma
Article | Year |
---|---|
Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Deferoxamine; Disease Mo | 2011 |
Differential modulation of the RNA-binding proteins IRP-1 and IRP-2 in response to iron. IRP-2 inactivation requires translation of another protein.
Topics: 3T3 Cells; Animals; Cycloheximide; Cytidine Triphosphate; Dactinomycin; Deferoxamine; Iron; Iron Reg | 1995 |
Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences.
Topics: Animals; Base Sequence; Binding Sites; Cell Line; Cycloheximide; Deferoxamine; HeLa Cells; HL-60 Cel | 1996 |
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.
Topics: Animals; Bleomycin; Chemistry, Pharmaceutical; Colonic Neoplasms; Deferoxamine; Drug Carriers; Galli | 1990 |